Back to Search
Start Over
Exon junction complex shapes the m6A epitranscriptome.
- Source :
- Nature Communications; 12/23/2022, Vol. 13 Issue 1, p1-12, 12p
- Publication Year :
- 2022
-
Abstract
- N6-methyladenosine (m<superscript>6</superscript>A), the most abundant modification of mRNA, is essential for normal development and dysregulation promotes cancer. m<superscript>6</superscript>A is highly enriched in the 3' untranslated region (UTR) of a large subset of mRNAs to influence mRNA stability and/or translation. However, the mechanism responsible for the observed m<superscript>6</superscript>A distribution remains enigmatic. Here we find the exon junction complex shapes the m<superscript>6</superscript>A landscape by blocking METTL3-mediated m<superscript>6</superscript>A modification close to exon junctions within coding sequence (CDS). Depletion of EIF4A3, a core component of the EJC, causes increased METTL3 binding and m<superscript>6</superscript>A modification of short internal exons, and sites close to exon-exon junctions within mRNA. Reporter gene experiments further support the role of splicing and EIF4A3 deposition in controlling m<superscript>6</superscript>A modification via the local steric blockade of METTL3. Our results explain how characteristic patterns of m<superscript>6</superscript>A mRNA modification are established and uncover a role of the EJC in shaping the m<superscript>6</superscript>A epitranscriptome. Here the authors show the exon junction complex (EJC) component, EIF4A3, locally restricts METTL3- mediated mRNA methylation at exon junctions to explain the observed widespread enrichment of m6A modification in 3' untranslated regions. [ABSTRACT FROM AUTHOR]
- Subjects :
- REPORTER genes
ADENOSINES
MESSENGER RNA
Subjects
Details
- Language :
- English
- ISSN :
- 20411723
- Volume :
- 13
- Issue :
- 1
- Database :
- Complementary Index
- Journal :
- Nature Communications
- Publication Type :
- Academic Journal
- Accession number :
- 160937007
- Full Text :
- https://doi.org/10.1038/s41467-022-35643-1